Time Warner Inc.'s (NYSE:TWX) Warner Bros. pulled out another underestimated feather from its cap this weekend. Its gore and hack-fest film 300 has set what appears to be a record release for films in March. While the tally isn't in yet, Sunday estimates put ticket sales for the blood and gore movie (think Gladiator meets Sin City) at around $70 million. The movie's comic-book sequencing and graphic special effects allow decapitations and severed limbs to take on an entirely new light.
The best-guess estimate anyone had thrown out for the movie was up to $50 million. Its production costs on an end-to-end basis were roughly $60 million, putting the movie in the black after only three days. That is long before any DVD, video game or merchandise sales are registered in the coffers, either. It hasn't even opened in the UK as of yet. Analysts have been critical of Time Warner's movie revenues because there has been no Harry Potter nor Lord of The Rings to carry the rest of the movies. This will mark another major success for the unit.
For a company the size of Time Warner, one movie can't add enough to the bottom line to boost the earnings-per-share number. However, a successful movie can add up with others to contribute on the overage. It might also garner some stronger attention from analysts, who may have thought that only major franchise series movies can rule the roost.
One should also consider that this big surprise is coming in the last month of the quarter -- if this really racks up a huge profit in the next three weeks, analysts may have to increase some of their estimates. Two months ago and up until recently, the movie was not a write-off, but it wasn't expected to be nearly this big of a hit.
Here you can see the trailers and get soundtrack excerpts.
Last updated: February 12, 2012: 04:04 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Some walnut growers want to stop selling to Diamond, Reuters says
- EASA orders Airbus A380s to be inspected, Der Spiegel says
- Sikorsky signs MOU with ASESA
- Lider Aviacao buys three Sikorsky S-92 helicopters
- Aviva won't be selling Taiwan JV stake, Reuters says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?


Reader Comments (Page 1 of 1)
3-12-2007 @ 10:15PM
Arthur said...
Well actually the best figures Ive seen for the movie on the upward side of 70 million. Vancouver Sun mar 11.